Cerulean Pharma (CERU US): Synthetic Expert Call Transcript (29 Aug 2026)
The passive targeting paradigm based on the Enhanced Permeability and Retention (EPR) effect has largely failed in human clinical trials. While...
86 Views
IPO Databook: Daré Bioscience (DARE US) - Aug 2026
Daré Bioscience, Inc. is a purpose-driven health biotech company solely focused on women's health, advancing innovations from contraception to...
102 Views
No more insights